Concepedia

Author

Umberto Vitolo

Azienda Ospedaliera Citta' della Salute e della Scienza di TorinoORCID

Also Known As

Barbara Botto, Daniele Vallisa, Joris Verlooy, S. Hohaus, U Vitolo, U. Vitolo, UMBERTO VITOLO, Umbero Vitolo, Umberto Vitolo, Vitolo, U.

642

Publications

20.8K

Citations

76

H-Index

116

Concepts

All Affiliations

Azienda Ospedaliera Citta' della Salute e della Scienza di TorinoAzienda Ospedaliero Universitaria San Giovanni BattistaIstituti di Ricovero e Cura a Carattere ScientificoSapienza University of RomeUniversity of Turin
UV

About

Umberto Vitolo is an author at Azienda Ospedaliera Citta' della Salute e della Scienza di Torino specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

45

87

7K

2

Health Sciences

26

40

3.3K

3

Public Health

4

4

216

4

Blood Transplantation

3

3

217

5

Engineering

1

1

21

Umberto Vitolo

×

200

Publications

18.4K

Citations

72

H-Index

YearCitations

Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Hervé Tilly, María Gomes da Silva, Umberto Vitolo,

Annals of Oncology

2015

900

Early Interim 2-[ <sup>18</sup> F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

Andrea Gallamini, Martin Hutchings, Luigi Rigacci,

Journal of Clinical Oncology

2007

829

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

Massimo Federico, Monica Bellei, Luigi Marcheselli,

Journal of Clinical Oncology

2009

736

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro,

The Lancet

2018

707

Follicular lymphoma international prognostic index.

Pascal Roy, Philippe Colombat, Josephine M White,

PubMed

2004

627

Phase III Trial of Consolidation Therapy With Yttrium-90–Ibritumomab Tiuxetan Compared With No Additional Therapy After First Remission in Advanced Follicular Lymphoma

Franck Morschhauser, John Radford, Achiel Van Hoof,

Journal of Clinical Oncology

2008

458

Patterns of Outcome and Prognostic Factors in Primary Large-Cell Lymphoma of the Testis in a Survey by the International Extranodal Lymphoma Study Group

Emanuele Zucca, Annarita Conconi, Tariq I. Mughal,

Journal of Clinical Oncology

2002

441

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

Simonetta Viviani, Pier Luigi Zinzani, Alessandro Rambaldi,

New England Journal of Medicine

2011

419

Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

Umberto Vitolo, Marek Trněný, David Belada,

Journal of Clinical Oncology

2017

414

The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.

Andrea Gallamini, Luigi Rigacci, Francesco Merli,

PubMed

2006

294

Page 1